​

Stryker (SYK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SYK Stock Forecast

Stryker (SYK) stock forecast, based on 50 Wall Street analysts, predicts a 12-month average price target of $425.58, with a high of $469.00 and a low of $390.00. This represents a 17.43% increase from the last price of $362.42.

$250 $300 $350 $400 $450 $500 High: $469 Avg: $425.58 Low: $390 Last Closed Price: $362.42

SYK Stock Rating

Stryker stock's rating consensus is Buy, based on 50 Wall Street analysts. The breakdown includes 1 Strong Buy (2.00%), 35 Buy (70.00%), 14 Hold (28.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 50 14 35 1 Strong Sell Sell Hold Buy Strong Buy

SYK Price Target Upside V Benchmarks

TypeNameUpside
StockStryker17.43%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks22.61%

Price Target Trends

1M3M12M
# Anlaysts61121
Avg Price Target$439.33$429.73$421.86
Last Closing Price$362.42$362.42$362.42
Upside/Downside21.22%18.57%16.40%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 269128-130
Jan, 268138-130
Dec, 2571310-131
Nov, 2571310-131
Oct, 2571310-131
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 02, 2026Barclays$469.00$369.5626.91%29.41%
Jan 30, 2026Mike MatsonNeedham$454.00$365.6224.17%25.27%
Jan 30, 2026Robert W. Baird$437.00$369.0218.42%20.58%
Jan 30, 2026Ryan ZimmermanBTIG$412.00$354.3016.29%13.68%
Jan 09, 2026Lee HambrightBernstein$465.00$367.2126.63%28.30%
Jan 09, 2026Goldman Sachs$399.00$367.218.66%10.09%
Jan 06, 2026Raymond James$418.00$348.7919.84%15.34%
Jan 05, 2026Evercore ISI$390.00$347.6912.17%7.61%
Nov 14, 2025Richard NewitterTruist Financial$400.00$366.389.18%10.37%
Nov 14, 2025Shagun SinghRBC Capital$435.00$365.1419.13%20.03%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 02, 2026BarclaysOverweightOverweighthold
Jan 30, 2026NeedhamBuyBuyhold
Jan 30, 2026CitigroupMarket OutperformMarket Outperformhold
Jan 30, 2026BTIGBuyBuyhold
Jan 27, 2026Piper SandlerOverweightOverweighthold
Jan 26, 2026Cowen & Co.BuyHolddowngrade
Jan 09, 2026BernsteinOutperformOutperformhold
Jan 06, 2026Raymond JamesOutperformupgrade
Dec 19, 2025CitigroupBuyOutperformupgrade
Dec 11, 2025CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$5 $9 $13 $17 $21 $25 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$5.29$6.23$8.34$7.86-----
Avg Forecast$9.11$9.18$10.41$12.05$13.49$14.92$16.63$18.36$20.61
High Forecast$9.20$9.30$10.45$12.09$13.62$15.22$17.86$18.71$21.00
Low Forecast$8.97$9.05$10.37$12.02$13.28$14.60$15.65$18.00$20.20
Surprise %-41.93%-32.14%-19.88%-34.77%-----

Revenue Forecast

$15B $19B $23B $27B $31B $35B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$17.11B$18.45B$20.50B$22.59B-----
Avg Forecast$17.06B$18.21B$20.28B$22.52B$24.46B$26.37B$28.62B$31.09B$33.43B
High Forecast$17.18B$18.40B$20.41B$22.64B$24.75B$26.89B$28.69B$31.54B$33.92B
Low Forecast$16.86B$18.02B$20.23B$22.43B$24.17B$25.98B$28.54B$30.61B$32.91B
Surprise %0.29%1.32%1.05%0.32%-----

Net Income Forecast

$2B $3B $4B $6B $7B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.99B$2.36B$3.17B$2.99B-----
Avg Forecast$1.98B$2.16B$3.17B$4.63B$5.16B$5.72B$6.43B$7.05B$7.91B
High Forecast$2.38B$2.59B$3.80B$4.64B$5.23B$5.84B$6.85B$7.18B$8.06B
Low Forecast$1.59B$1.73B$2.53B$4.61B$5.10B$5.60B$6.01B$6.91B$7.75B
Surprise %0.47%9.14%--35.32%-----

SYK Forecast FAQ

Is Stryker stock a buy?

Stryker stock has a consensus rating of Buy, based on 50 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 35 Buy, 14 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Stryker is a favorable investment for most analysts.

What is Stryker's price target?

Stryker's price target, set by 50 Wall Street analysts, averages $425.58 over the next 12 months. The price target range spans from $390 at the low end to $469 at the high end, suggesting a potential 17.43% change from the previous closing price of $362.42.

How does Stryker stock forecast compare to its benchmarks?

Stryker's stock forecast shows a 17.43% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (22.61%).

What is the breakdown of analyst ratings for Stryker over the past three months?

  • February 2026: 30.00% Strong Buy, 40.00% Buy, 26.67% Hold, 0% Sell, 3.33% Strong Sell.
  • January 2026: 26.67% Strong Buy, 43.33% Buy, 26.67% Hold, 0% Sell, 3.33% Strong Sell.
  • December 2025: 22.58% Strong Buy, 41.94% Buy, 32.26% Hold, 0% Sell, 3.23% Strong Sell.

What is Stryker’s EPS forecast?

Stryker's average annual EPS forecast for its fiscal year ending in December 2025 is $13.49, marking a 71.63% increase from the reported $7.86 in 2024. Estimates for the following years are $14.92 in 2026, $16.63 in 2027, $18.36 in 2028, and $20.61 in 2029.

What is Stryker’s revenue forecast?

Stryker's average annual revenue forecast for its fiscal year ending in December 2025 is $24.46B, reflecting a 8.25% increase from the reported $22.6B in 2024. The forecast for 2026 is $26.37B, followed by $28.62B for 2027, $31.09B for 2028, and $33.43B for 2029.

What is Stryker’s net income forecast?

Stryker's net income forecast for the fiscal year ending in December 2025 stands at $5.16B, representing an 72.46% increase from the reported $2.99B in 2024. Projections indicate $5.72B in 2026, $6.43B in 2027, $7.05B in 2028, and $7.91B in 2029.